# Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

> **NCT00104767** · PHASE1 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00104767
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2015-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104767, "Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00104767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*